Latest

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
14% inoculated with COVID precautionary dose till now in Odisha: Top health official
Covishield Vaccine Prices Slashed For Private Hospitals
2nd Covishield Dose Now Allowed Between 8-16 Weeks After First Jab: NTAGI 
Covaxin, Covishield Shoots Down Omicron Wave In India, USA Waits For Omicron-Specific Vaccine
Regular Market Approval Granted For Covishield, Covaxin For Use In Adult Population
Covishield, Covaxin Cleared For Regular Market Approval
Total of 158.74 Cr COVID-19 Vaccine Doses Administered; Over 3.7 Cr In 15-18 Age Group Get First Dose
Will Booster Dose Give Protection From Omicron: 3.4% Of Vaccinated Positives In India Took 3-doses
Covishield Found 63% Effective In Fully Vaccinated Individuals During 2nd Surge
Serum Institute Resumes Export Of Covishield To COVAX
Nepal, India to recognise Covid vax certification
© 2025 - Odisha Television Limited. All Rights Reserved.